Cytoskeleton vimentin disruption of mouse sertoli cells injured by nitrogen mustard in vitro

Journal of Andrology

Volumn 28, Issue 3, 2007, Pages 389-396

  He, Dawei ^a   Zhang, Deying ^a   Wei, Guanghui ^a   Lin, Tao ^a   Li, Xuliang ^a  

^a CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Testis

Indexed keywords

ALKYLATING AGENT; CHLORMETHINE; MESSENGER RNA; VIMENTIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL DISRUPTION; CONTROLLED STUDY; CYTOSKELETON; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INTERMEDIATE FILAMENT; MALE; MORPHOLOGICAL TRAIT; MOUSE; NONHUMAN; OPTICAL DENSITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERTOLI CELL; WESTERN BLOTTING;

ALKYLATING AGENTS; ANIMALS; BLOTTING, WESTERN; CYTOSKELETON; GENE EXPRESSION; MALE; MECHLORETHAMINE; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SERTOLI CELLS; VIMENTIN;

EID: 34247534514     PISSN: 01963635     EISSN: None     Source Type: Journal    
DOI: 10.2164/jandrol.106.000455     Document Type: Article

References (26)

1. Allard EK, Johnson KJ, Boekelheide K. Colchicine disrupts the cytoskeleton of rat testis seminiferous epithelium in a stage-dependent manner. Biol Reprod. 1993;48:143-153.
2. Amlani S, Vogl AW. Changes in the distribution of microtubules and intermediate filaments in mammalian Sertoli cells during spermatogenesis. Anat Rec. 1988;220:143-160.
3. Aumuller G, Schulze C, Viebahn C. Intermediate filaments in Sertoli cells. Microsc Res Tech. 1992;20:50-72.
4. Aumuller G, Steinbruck M, Krause W, Wagner HJ. Distribution of vimentin-type intermediate filaments in Sertoli cells of the human testis, normal and pathologic. Anat Embryol (Berl). 1988;178:129-136.
5. Boekelheide K, Neely MD, Sioussat TM. The Sertoli cell cytoskeleton: a target for toxicant-induced germ cell loss. Toxicol Appl Pharmacol. 1989;101:373-389.
6. Byrne J, Mulvihill JJ, Myers MH, Connelly RR, Naughton MD, Krauss MR, Steinhorn SC, Hassinger DD, Austin DF, Bragg K, et al. Effects of treatment on fertility in long-term survivors of childhood or adolescent cancer. N Engl J Med. 1987;317:1315-1321.
7. Dalgaard M, Hossaini A, Hougaard KS, Hass U, Ladefoged O. Developmental toxicity of toluene in male rats: effects on semen quality, testis morphology, and apoptotic neurodegeneration. Arch Toxicol. 2001;75:103-109.
8. de Kretser DM, Loveland KL, Meinhardt A, Simorangkir D, Wreford N. Spermatogenesis. Hum Reprod. 1998;13(suppl 1):1-8.
9. Franke WW, Grund C, Schmid E. Intermediate-sized filaments present in Sertoli cells are of the vimentin type. Eur J Cell Biol. 1979;19:269-275.
10. Franke WW, Schmid E, Schiller DL, Winter S, Jarasch ED, Moll R, Denk H, Jackson BW, Illmensee K. Differentiation-related patterns of expression of proteins of intermediate-size filaments in tissues and cultured cells. Cold Spring Harb Symp Quant Biol. 1982;46:431-453.
11. Fuchs E, Cleveland DW. A structural scaffolding of intermediate filaments in health and disease. Science. 1998;279:514-519.
12. Galdieri M, Zani B. Hormonal induced changes in Sertoli cell glycoproteins. Cell Biol Int Rep. 1981;5:111.
13. Johnson KJ, Hall ES, Boekelheide K. 2,5-Hexanedione exposure alters the rat Sertoli cell cytoskeleton. I. Microtubules and seminiferous tubule fluid secretion. Toxicol Appl Pharmacol. 1991;111:432-442.
14. Klymkowsky MW, Bachant JB, Domingo A. Functions of intermediate filaments. Cell Motil Cytoskeleton. 1989;14:309-331.
15. Langford KG, Zhou Y, Russell LD, Wilcox JN, Bernstein KE. Regulated expression of testis angiotensin-converting enzyme during spermatogenesis in mice. Biol Reprod. 1993;48:1210-1218.
16. Lloyd SC, Foster PM. Effect of mono-(2-ethylhexyl)phthalate on follicle-stimulating hormone responsiveness of cultured rat Sertoli cells. Toxicol Appl Pharmacol. 1988;95:484-489.
17. Muffly KE, Nazian SJ, Cameron DF. Junction-related Sertoli cell cytoskeleton in testosterone-treated hypophysectomized rats. Biol Reprod. 1993;49:1122-1132.
18. Nicholson HS, Byrne J. Fertility and pregnancy after treatment for cancer during childhood or adolescence. Cancer. 1993;71(suppl 10):3392-3399.
19. Pauwels O, Atassi G, Kiss R. Combination of computerized morphonuclear and multivariate analyses to characterize in vitro the antineoplastic effect of alkylating agents. J Pharmacol Toxicol Methods. 1995;33:35-45.
20. Richburg JH, Boekelheide K. Mono-(2-ethylhexyl) phthalate rapidly alters both Sertoli cell vimentin filaments and germ cell apoptosis in young rat testes. Toxicol Appl Pharmacol. 1996;137:42-50.
21. Rueffer U, Breuer K, Josting A, Lathan B, Sieber M, Manzke O, Grotenhermen FJ, Tesch H, Bredenfeld H, Koch P, Nisters-Backes H, Wolf J, Engert A, Diehl V. Male gonadal dysfunction in patients with Hodgkin's disease prior to treatment. Ann Oncol. 2001;12:1307-1311.
22. Russell LD, Bartke A, Goh JC. Postnatal development of the Sertoli cell barrier, tubular lumen, and cytoskeleton of Sertoli and myoid cells in the rat, and their relationship to tubular fluid secretion and flow. Am J Anat. 1989;184:179-189.
23. Show MD, Anway MD, Folmer JS, Zirkin BR. Reduced intratesticular testosterone concentration alters the polymerization state of the Sertoli cell intermediate filament cytoskeleton by degradation of vimentin. Endocrinology. 2003;144:5530-5536.
24. Takase M, Tsutsui K, Kawashima S. Inhibitory effect of Sertoli cell-cultured media on LH binding to mouse Leydig cells in culture. Endocrinol Jpn. 1988;35:285-293.
25. Tung PS, Burdzy K, Fritz IB. Proteases are implicated in the changes in the Sertoli cell cytoskeleton elicited by follicle-stimulating hormone or by dibutyryl cyclic AMP. J Cell Physiol. 1993;155:139-148.
26. Wang ZQ, Watanabe Y, Toki A, Itano T. Altered distribution of Sertoli cell vimentin and increased apoptosis in cryptorchid rats. J Pediatr Surg. 2002;37:648-652.